Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Biomerica Inc (BMRA)

Biomerica Inc (BMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,548
  • Shares Outstanding, K 16,822
  • Annual Sales, $ 5,340 K
  • Annual Income, $ -7,140 K
  • 60-Month Beta -1.08
  • Price/Sales 1.38
  • Price/Cash Flow N/A
  • Price/Book 0.95
Trade BMRA with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.37
  • Most Recent Earnings $-0.11 on 04/12/24
  • Next Earnings Date 08/23/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 327.99% ( +19.08%)
  • Historical Volatility 75.45%
  • IV Percentile 43%
  • IV Rank 14.07%
  • IV High 1,290.73% on 10/09/23
  • IV Low 170.31% on 09/19/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 798
  • Volume Avg (30-Day) 287
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 317
  • Open Int (30-Day) 520

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4005 +12.03%
on 06/21/24
0.6100 -26.44%
on 06/04/24
-0.1373 (-23.43%)
since 06/03/24
3-Month
0.4005 +12.03%
on 06/21/24
0.8900 -49.58%
on 04/11/24
-0.3857 (-46.22%)
since 04/03/24
52-Week
0.4005 +12.03%
on 06/21/24
2.1300 -78.93%
on 12/18/23
-0.8413 (-65.22%)
since 07/03/23

Most Recent Stories

More News
Walmart to Begin Selling Biomerica’s Aware® Breast Self Exam

Simple at-home device to increase sensitivity in breast self examsEarly detection of breast cancer saves livesBreast Cancer accounts for 1 in 3 new cases...

BMRA : 0.4487 (+0.83%)
Biomerica to Participate at BTIG Biotech Conference

IRVINE, Calif., June 23, 2022 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced that the Company’s CEO will participate at the 2022 BTIG...

BMRA : 0.4487 (+0.83%)
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022

RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies...

ACST : 2.90 (+1.75%)
LPTH : 1.3700 (-1.44%)
RCAT : 1.1700 (unch)
IONM : 0.3125 (-5.93%)
PYR : 0.3799 (unch)
OSS : 2.19 (-0.45%)
MODD : 1.4000 (-9.09%)
STRN : 1.3400 (+0.75%)
AEYE : 21.26 (+7.43%)
SMFL : 2.72 (-2.86%)
LFMD : 6.81 (+2.87%)
SURG : 2.91 (-6.73%)
Biomerica Announces CE Mark for Its H. pylori Diagnostic Test, hp+detect™

- Attaining CE Mark is a major step toward commercialization – - World Health Organization (WHO) lists H. pylori among the 16 antibiotic-resistant...

BMRA : 0.4487 (+0.83%)
Biomerica Announces FDA Submission For a Test to Detect Helicobacter pylori (H. pylori), a Bacteria That Infects Approximately 35% of the US Population

Gastric cancer is the third most common cause of cancer related death in the world and over 80% of gastric cancers are attributed to H. pylori bacterial...

BMRA : 0.4487 (+0.83%)
Biomerica Reports 111% Increase in Q3 Fiscal 2022 Revenues to $7.6 million vs. Q3 Fiscal 2021

Q3 Net loss per share of $0.01 vs. a net loss of $0.18 per share from same period last year InFoods® IBS diagnostic-guided therapy clinical trial results...

BMRA : 0.4487 (+0.83%)
Biomerica Announces Positive Topline Results from the Endpoint Clinical Trial of its InFoods® IBS Treatment for Patients with Irritable Bowel Syndrome

InFoods® IBS Diagnostic-Guided Therapy is the first therapy of its kind using science, diet and technology to identify patient specific foods, which when...

BMRA : 0.4487 (+0.83%)
Biomerica Reports Record Financial Results for Fiscal Second Quarter ended November 30, 2021

Revenues up 239% over prior year fiscal second quarter  Customer orders backlog of over $4.0 million at November 30, 2021  Walmart began in-store and...

BMRA : 0.4487 (+0.83%)
Biomerica Announces Preliminary Second Quarter Revenue Increase of Approximately 238%, to Approximately $4.6 Million

InFoods® IBS Clinical Trial on Track for Completion in December with Topline Results Expected to be Announced in January, 2022. IRVINE, Calif., Dec. 16,...

BMRA : 0.4487 (+0.83%)
Biomerica Forms Scientific Advisory Board for Colorectal Cancer Screening

Chaired by Dr. Brooks Cash, Chief of Gastroenterology and Hepatology at the University of Texas Health Center at HoustonScientific Advisory Board to guide...

BMRA : 0.4487 (+0.83%)

Business Summary

BIOMERICA, INC. is an emerging-growth biotechnology firm that develops, manufactures and distributes medical diagnostic products. The Company is focused on niche products for early detection and monitoring of human diseases and conditions before they become catastrophic and incurable. The customers include...

See More

Key Turning Points

3rd Resistance Point 0.4921
2nd Resistance Point 0.4784
1st Resistance Point 0.4635
Last Price 0.4487
1st Support Level 0.4349
2nd Support Level 0.4212
3rd Support Level 0.4063

See More

52-Week High 2.1300
Fibonacci 61.8% 1.4693
Fibonacci 50% 1.2653
Fibonacci 38.2% 1.0612
Last Price 0.4487
52-Week Low 0.4005

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar